N
Noblegen
Biotech & Life Sciences · Peterborough, Canada · Founded 2013
Advanced ingredients company that produces unique proteins and oils for the healthy living industry MoreLess
Noblegen is a pioneering life sciences company dedicated to creating sustainable solutions that challenge conventional practices. The company operates in the biotechnology sector, focusing on innovative products that have a positive impact on both human health and the environment. Noblegen serves a diverse range of clients, including food and beverage manufacturers, health and wellness companies, and other industries seeking sustainable alternatives. The business model revolves around leveraging its proprietary Euglena-based technology to develop and commercialize groundbreaking products. Revenue is generated through the sale of these innovative solutions and through strategic partnerships and collaborations.
Noblegen's market is global, targeting industries that are increasingly prioritizing sustainability and health. The company's unique approach involves questioning norms and taking non-linear paths to solve complex global problems. This strategy not only sets them apart but also accelerates the development of impactful solutions.
Keywords: biotechnology, sustainability, Euglena, palm oil replacement, vegan protein, innovation, health, environment, non-linear solutions, global impact.
Company overview
Noblegen company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2013
- Headquarters
- Peterborough, Canada
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 62.5
Valuation & funding
Noblegen funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jul 2023 | $0 | — | Solar Biotech | ↗ |
| SERIES B✓Equity / VC | May 2019 | $18M | $72M | BDC Capital · Business Development Bank of Canada · Richardson Ventures | — |
| SERIES A✓Equity / VC | Jan 2016 | $9.5M | $38M | Undisclosed | — |
| SPINOUT✓Other financing | Sep 2013 | $0 | — | Trent University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 10 |
| 2025 | 26 |
| 2024 | 26 |
| 2023 | 26 |
| 2022 | 37 |
| 2021 | 50 |
| 2020 | 66 |
Growth signals
Noblegen website traffic
Latest recorded traffic for Noblegen is 1.6K monthly website visits, up 1500% over the last three months. Noblegen's team declined 61.5% over the past year.
Comparisons
Noblegen compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Noblegen's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Noblegen has talent and traffic
team presence
In the news
Latest news about Noblegen
Recent press, funding announcements, and product moves mentioning Noblegen — open to read from the original sources.
Market sentiment
What the market is saying about Noblegen
An AI-synthesized read of the highest-engagement posts about Noblegen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Noblegen’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.